References
- Alcazar JL, Jurado M, Lopez-Garcia G (1999). Comparative study of transvaginal ultrasonography and CA 125 in the preoperative evaluation of myometrial invasion in endometrial carcinoma. Ultrasound Obstet Gynecol, 14, 210-4. https://doi.org/10.1046/j.1469-0705.1999.14030210.x
- Atasu T, Sahmay S (2001). The malignant diseases of the uterus. In 'Gynecology', Eds Atasu T and Sahmay S. Nobel Medicine Bookstore Press, Istanbul, 299-322.
- Chan JK, Kapp DS (2007). Role of complete lymphadenectomy in endometrioid uterine cancer. Lancet Oncol, 8, 831-41. https://doi.org/10.1016/S1470-2045(07)70275-9
- Chao A, Tang YH, Lai CH, et al (2013). Potential of an age-stratified CA125 cut-off value to improve the prognostic classification of patients with endometrial cancer. Gynecol Oncol, 129, 500-4. https://doi.org/10.1016/j.ygyno.2013.02.032
- Chen YL, Huang CY, Chien TY, et al (2011). Value of preoperative serum CA-125 level for prediction of prognosis in patients with endometrial cancer. Aust N Z J Obstet Gynaecol, 51, 397-402. https://doi.org/10.1111/j.1479-828X.2011.01325.x
- Chung H, Kim JW, Park N, et al (2006). Use of preoperative serum CA-125 levels for prediction of lymph node metastasis and prognosis in endometrial cancer. Acta Obstetrica et Gynecologica, 85, 1501-5. https://doi.org/10.1080/00016340601022777
- Dotters D (2000). Preoperative Ca-125 in endometrial cancer:is it useful? Am J Obstet Gynecol, 182, 1328 -35. https://doi.org/10.1067/mob.2000.106251
- Dvalishvili I, Charkviani L, Turashvili G, et al (2006). Clinical characteristics of prognostic factors in uterine endomet-rioid adenocarcinoma of various grade. Georgian Med News, 132, 24-7.
- Gadduci A Cosio S, Genazzani AR (2011). Tissue and serum biomarkers as prognostic variables in endometrioid-type endometrial cancer. Crit Rev Oncol Hematol, 80, 181-92. https://doi.org/10.1016/j.critrevonc.2010.11.005
- Geisinger KR, Homesley HD, Morgan TM, et al (2006). Endometrial adenocarcinoma: a multiparameter clinicopathologic analysis including the DNA profile and sex hormone receptors. Cancer, 58, 1518-25.
- Goksedef BP, Gorgen H, Baran SY, et al (2011). Preoperative serum CA 125 level as a predictor for metastasis and survival in endometrioid endometrial cancer. J Obstet Gynaecol Can, 33, 844-50. https://doi.org/10.1016/S1701-2163(16)34988-X
- Hsieh Ch, Chien CC, Lin H (2008). Can a preoperative Ca 125 level be a criteration for full pelvic lympadenectomy in surgical staging of endometrial cancer? Gynecol Oncol, 86, 28-33.
- Jemal A, Murray T, Ward E, et al (2005). Cancer statistics, 2005. CA Cancer J Clin, 55, 10-30. https://doi.org/10.3322/canjclin.55.1.10
- Jemal A, Siegel R, Ward E, et.al (2006). Cancer statistics. CA Cancer J Clin, 56, 106-30. https://doi.org/10.3322/canjclin.56.2.106
- John A. Rock, John D. Thompson (2007). Malignant Tumors of the Uterin Corpus, incidence. Te Linde's Operative Gynecol, 50, 1503.
- Kang S, Kang WD, Chung HH, et al (2012). Preoperative identification of a low-risk group for lymph node metastasis in endometrial cancer: a Korean gynecologic oncology group study. J Clin Oncol, 30, 1329-34. https://doi.org/10.1200/JCO.2011.38.2416
- Kukura V, Zovko G Ciglar S, et al (2003). Serum CA-125 tumor marker in endometrial adenocarcinoma. Eur J Gynecol Oncol, 24, 151-3.
- Kurihara T, Mizunuma H, Obara M, et al (1998). Determination of a normal level of serum CA125 in postmenopausal women as a tool for preoperative evaluation and postoperative surveillance of endometrial carcinoma. Gynecol Oncol, 69, 192-6. https://doi.org/10.1006/gyno.1998.5018
- Lo S, Cheng D, NG T (1997). Prognostic significance of tumor markers in endometrial cancer. Tumor Biol, 18, 241-9. https://doi.org/10.1159/000218037
- Longacre TA, Kempson RL, Hendrickson MR (2005). Endometrial Hyperplasia, Metaplasia and Carcinoma. Obstetri-cal and Gynecological Pathology. 4th Edition. Churchill Livingstone, New York, 421-511.
- Powell JL, Hill KA, Shiro BC, et al (2005). Preoperative serum CA12-5 levels in treating endometrial cancer. J Reproductive Med, 50, 585-90.
- Price FV, Chambers SK, Carcangiu ML, et al (1998). Ca-125 may not reflect disease status in patients uterin seros carcinoma. Cancer, 82, 1720-5. https://doi.org/10.1002/(SICI)1097-0142(19980501)82:9<1720::AID-CNCR19>3.0.CO;2-6
- Yildiz A, Ozcan A, Yetimalar MH, et al (2013). The Predictability of Lymph Node Metastasis in Patients with Endometrial Cancer. Turkiye Klinikleri J Med Sci, 33, 1028-36. https://doi.org/10.5336/medsci.2012-31986
- Yildiz A, Yetimalar H, Kasap B, et al (2012). Preoperative serum Ca-125 level in the prediction of the stage of disease in endometrial carcinoma. Eur J Obstet Gynecol Reprod Biol, 164, 191-5. https://doi.org/10.1016/j.ejogrb.2012.05.038